Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Now - look at Wallace's work related to western diets ...
View:
Post by MrMugsy on Sep 03, 2022 6:51pm

Now - look at Wallace's work related to western diets ...

When you now look at the news about ultra-processed foods and you compare it to what Wallace was saying in 2021 about Aspriin-H2S ... you get a feeling for where this is going.

Just need to look at conclusion and discussion sections for confirmation that H2S can be a force in this space.

Not surprising !

This is the report that Wallace did with the Ukranian Scientists (may have already shared but now the contest is easier to see).

https://www.researchgate.net/publication/353201086_Hydrogen_Sulfi_de-releasing_anti-infl_ammatory_drug_ATB-340_treatment_potentially_reduces_mesenteric_metafl_ammation_in_the_experimental_age-and_high_fructose_dietary-induced_injury
Comment by Pandora on Sep 03, 2022 10:02pm
That looks like July 20221??
Comment by Pandora on Sep 03, 2022 10:03pm
Make that 2021!
Comment by MrMugsy on Sep 04, 2022 8:46am
Correct - this is recent work. Obviously 340 would required a redesign but that's in line with IBD and the new antiviral (ATB-344).  It would likely morph out of the learning that comes from those designs ... and ... it would likely come with 20 year IP. But ... too much on the go ... I'm not looking for any quick move into 340 at this time. ------------------------ Too much ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities